| http://www.w3.org/ns/prov#value | - Despite their great efficacy in treating these inflammatory conditions, these antibodies have proved unsuccessful in treating obesity-related inflammation and type 2 diabetes (9, 10), perhaps because obesity-induced inflammation in humans is a more complex process that involves cytokines and chemokines other than TNF-??, such as adiponectin, leptin, IL-6, resistin, monocyte chemoattractant protein
|
